Speaker illustration

Doctor Carly Worden

Janssen Pharmaceuticals, Titusville (United States of America)

Member of:

European Society of Cardiology

Dr. Paoli, PharmD, MPH, is a health economist trained at the University of California, San Francisco. After completing her Doctor of Pharmacy in 2009, she completed a health economics and outcomes research fellowship which was a join appointment between USCF and Amgen. She currently works at Janssen Pharmaceuticals supporting Pulmonary Arterial Hypertension. She has over 12 years experience working in the pharmaceutical industry on research that includes cost-effectiveness modeling, epidemiology, disease burden, quality of life and incidence/prevalence. She has numerous awards including the 2019 Best Industry Poster award at the American Association of Clinical Chemistry. In her free time, Dr. Paoli likes to go on adventures with her husband and two children. She enjoys baseball and wine tasting.

Comparison of clinical and economic burden of pulmonary arterial hypertension patients with and without connective tissue disease treated with macitentan

Event: ESC Congress 2022

Topic: Treatment

Session: Hypertension - Treatment lifestyle and pharmacotherapy

Thumbnail

This platform is supported by

logo Novo Nordisk